Related Experiment Videos
Selective enrichment in human megakaryocyte progenitors by the B203.13 surface differentiation antigen
1Department of Biomedical Sciences and Biotechnology, Human Anatomy Section, Brescia, Italy.
Abstract:
The B203.13 monoclonal antibody specifically recognizes a subset (8-18.5%) of human CD34+ haemopoietic progenitors, which are significantly (P<0.05) enriched in megakaryocyte progenitors (CFU-meg). Moreover B203.13 expression was progressively lost as maturation proceeded along the megakaryocytic lineage. In fact: (i) CFU-meg derived from CD34+/B203.13+ showed a greater number of cells/colony with respect to CD34+/B203.13-; (ii) after 10 d of liquid cultures with 100 ng/ml of thrombopoietin, only a minority of CD34-derived cells positive for CD41 coexpressed B203.13; (iii) in situ immunocytochemical staining revealed that B203.13 was expressed exclusively on immature megakaryoblasts; (iv) circulating platelets did not express B203.13.
Insights
The B203.13 antibody identifies a specific subset of hematopoietic stem cells (HSCs) crucial for megakaryocyte development. Its expression diminishes as cells mature, indicating its role in early megakaryopoiesis.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Human CD34+ cells are hematopoietic stem and progenitor cells (HSPCs).
- Megakaryocyte progenitors (CFU-meg) are critical for platelet production.
- Understanding early megakaryopoiesis requires identifying specific progenitor markers.
Purpose of the Study:
- To characterize the expression of the B203.13 monoclonal antibody on human hematopoietic progenitors.
- To investigate the role of B203.13 in megakaryocytic lineage commitment and maturation.
Main Methods:
- Flow cytometry analysis of human CD34+ cells.
- In vitro culture of megakaryocyte progenitors (CFU-meg) with thrombopoietin.
- In situ immunocytochemical staining for B203.13 expression on megakaryoblasts.
Main Results:
- B203.13 specifically recognizes 8-18.5% of CD34+ cells, enriched for CFU-meg.
- B203.13 expression is progressively lost during megakaryocytic maturation.
- B203.13 is exclusively expressed on immature megakaryoblasts and not on circulating platelets.
Conclusions:
- B203.13 is a novel marker for immature megakaryocyte progenitors within the CD34+ population.
- The B203.13 antibody can be used to study early megakaryopoiesis and progenitor cell dynamics.